On July 15, 2025, analyst Kristen Owen from Oppenheimer provided a key update on Bioceres Crop Solutions (BIOX, Financial). The firm maintained its "Outperform" rating on the stock while adjusting its price target (PT).
The price target for Bioceres Crop Solutions (BIOX, Financial) was lowered from USD 7.00 to USD 6.00, representing a decrease of 14.29%. Despite this adjustment, the "Outperform" rating indicates ongoing confidence in the company's prospects.
Investors following Bioceres Crop Solutions (BIOX, Financial) should note this revised valuation as part of their decision-making process.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 4 analysts, the average target price for Bioceres Crop Solutions Corp (BIOX, Financial) is $7.63 with a high estimate of $9.00 and a low estimate of $6.50. The average target implies an upside of 95.32% from the current price of $3.90. More detailed estimate data can be found on the Bioceres Crop Solutions Corp (BIOX) Forecast page.
Based on the consensus recommendation from 4 brokerage firms, Bioceres Crop Solutions Corp's (BIOX, Financial) average brokerage recommendation is currently 1.8, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Bioceres Crop Solutions Corp (BIOX, Financial) in one year is $10.26, suggesting a upside of 162.81% from the current price of $3.9039. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Bioceres Crop Solutions Corp (BIOX) Summary page.
